Agonist-Specific Regulation of μ-Opioid Receptor Desensitization and Recovery from Desensitization
Open Access
- 15 January 2008
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 73 (4), 1301-1308
- https://doi.org/10.1124/mol.107.042952
Abstract
Agonist-selective actions of opioids on the desensitization of μ-opioid receptors (MORs) have been well characterized, but few if any studies have examined agonist-dependent recovery from desensitization. The outward potassium current induced by several opioids was studied using whole-cell voltage-clamp recordings in locus ceruleus neurons. A brief application of the irreversible opioid antagonist β-chlornaltrexamine (β-CNA) was applied immediately after treatment of slices with saturating concentrations of opioid agonists. This approach permitted the measurement of desensitization and recovery from desensitization using multiple opioid agonists, including [Met]5enkephalin (ME), [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO), etorphine, fentanyl, methadone, morphine, morphine-6-glucuronide, oxycodone, and oxymorphone. The results indicate that desensitization protects receptors from irreversible antagonism with β-CNA. The amount of desensitization was measured as the decrease in current during a 10-min application of a saturating agonist concentration and was a good predictor of the extent of receptor protection from irreversible inactivation with β-CNA. After desensitization with ME or DAMGO and treatment with β-CNA, there was an initial profound inhibition of MOR-induced current that recovered significantly after 45 min. There was, however, no recovery of MOR-mediated current with time after treatment with agonists that did not cause desensitization, such as oxycodone. These results demonstrate that desensitization prevents irreversible inactivation of receptors by β-CNA.Keywords
This publication has 34 references indexed in Scilit:
- Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of μ-opioid receptors and dynamin-2European Journal of Pharmacology, 2007
- Agonist-Selective Mechanisms of μ-Opioid Receptor Desensitization in Human Embryonic Kidney 293 CellsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal CulturesJournal of Neuroscience, 2006
- Morphine-Induced μ-Opioid Receptor DesensitizationMolecular Pharmacology, 2005
- A cell biologist’s perspective on physiological adaptation to opiate drugsNeuropharmacology, 2004
- Receptor Endocytosis Counteracts the Development of Opioid TolerancePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Chronic Morphine Treatment Reduces Recovery from Opioid DesensitizationJournal of Neuroscience, 2004
- Phospholipase D2 modulates agonist‐induced µ‐opioid receptor desensitization and resensitizationJournal of Neurochemistry, 2003
- Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid ReceptorsPublished by Elsevier BV ,2003
- Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in VivoMolecular Pharmacology, 2002